BRTX [NASD]
BioRestorative Therapies, Inc.
Index- P/E- EPS (ttm)-12.48 Insider Own17.90% Shs Outstand3.64M Perf Week-0.63%
Market Cap12.25M Forward P/E- EPS next Y-3.63 Insider Trans1.96% Shs Float2.90M Perf Month4.34%
Income-34.60M PEG- EPS next Q-1.43 Inst Own20.90% Short Float / Ratio1.57% / 0.07 Perf Quarter5.03%
Sales0.10M P/S122.53 EPS this Y-30.60% Inst Trans3.52% Short Interest0.05M Perf Half Y7.56%
Book/sh4.66 P/B0.67 EPS next Y33.30% ROA-171.20% Target Price10.50 Perf Year-25.65%
Cash/sh4.19 P/C0.74 EPS next 5Y- ROE-178.80% 52W Range2.46 - 5.97 Perf YTD13.82%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-47.62% Beta-
Dividend %- Quick Ratio23.50 Sales past 5Y- Gross Margin- 52W Low27.24% ATR0.23
Employees7 Current Ratio23.50 Sales Q/Q262.50% Oper. Margin- RSI (14)51.79 Volatility5.59% 7.38%
OptionableNo Debt/Eq0.00 EPS Q/Q74.40% Profit Margin- Rel Volume0.07 Prev Close3.11
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume619.71K Price3.13
Recom2.00 SMA202.23% SMA502.71% SMA200-1.07% Volume5,568 Change0.64%
Mar-13-23 08:30AM
07:00AM
Mar-09-23 06:30AM
Mar-07-23 06:30AM
Mar-02-23 09:00AM
07:30AM Loading…
07:30AM
Feb-10-23 08:45AM
Feb-08-23 09:00AM
08:30AM
Feb-03-23 09:25AM
Jan-26-23 08:30AM
Jan-17-23 09:29AM
Dec-06-22 07:00AM
06:31AM
Dec-05-22 07:00AM
06:30AM Loading…
06:30AM
Nov-29-22 11:20AM
Nov-16-22 08:56AM
05:16AM
Nov-10-22 08:00AM
Oct-31-22 08:15AM
Oct-20-22 09:30AM
Oct-14-22 08:00AM
Sep-28-22 07:00AM
Sep-27-22 07:00AM
Sep-07-22 07:00AM
Sep-01-22 09:00AM
Aug-25-22 03:49PM
Aug-24-22 06:30AM
Jun-30-22 07:30AM
07:30AM Loading…
Jun-22-22 07:30AM
07:00AM
Jun-13-22 07:00AM
Apr-29-22 08:00AM
Apr-18-22 08:00AM
Apr-04-22 08:00AM
Mar-10-22 08:00AM
Feb-16-22 08:30AM
Feb-07-22 09:00AM
07:45AM
Feb-02-22 08:00AM
Jan-26-22 06:00AM
Jan-11-22 06:00AM
Jan-06-22 06:00AM
Jan-04-22 06:00AM
Dec-22-21 07:28AM
05:53AM
Dec-21-21 04:01PM
06:00AM
Dec-20-21 06:00AM
Dec-02-21 06:00AM
Nov-23-21 04:05PM
Nov-22-21 12:00PM
Nov-19-21 12:27PM
06:00AM
Nov-10-21 06:00AM
Nov-09-21 02:20PM
Nov-04-21 09:21PM
Oct-26-21 04:05PM
08:00AM
Sep-23-21 09:00AM
Sep-02-21 09:00AM
Aug-31-21 09:00AM
Aug-19-21 06:00AM
Aug-11-21 08:30AM
Aug-09-21 11:58AM
Jun-07-21 07:00AM
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadrick Dale10% OwnerFeb 22Buy2.866,00017,150305,073Mar 03 04:11 PM
ALSTODT LANCEPresident, CEO, COBFeb 01Buy3.104001,241187,321Feb 02 02:49 PM
ALSTODT LANCEPresident, CEO, COBJan 27Buy3.01200602186,921Jan 30 09:33 AM
ALSTODT LANCEPresident, CEO, COBJan 20Buy3.13200627186,721Jan 24 12:27 PM
ALSTODT LANCEPresident, CEO, COBJan 18Buy3.114001,244186,521Jan 20 08:19 AM
ALSTODT LANCEPresident, CEO, COBJan 09Buy3.08100308186,121Jan 10 06:06 PM
ALSTODT LANCEPresident, CEO, COBDec 23Buy3.01300903186,021Dec 28 08:22 AM
ALSTODT LANCEPresident, CEO, COBDec 07Buy2.991,8005,375185,721Dec 07 06:04 PM
Broadrick Dale10% OwnerNov 30Buy2.77200555299,073Mar 03 04:11 PM
Silva FranciscoVP of Research and DevelopmentNov 21Buy2.629432,467166,046Nov 21 05:14 PM
ALSTODT LANCEPresident, CEO, COBNov 18Buy2.881,0002,876183,921Nov 21 07:49 AM
Silva FranciscoVP of Research and DevelopmentOct 12Buy3.397252,457165,103Oct 12 02:01 PM
Silva FranciscoVP of Research and DevelopmentOct 11Buy3.698062,973164,378Oct 12 08:54 AM
Broadrick Dale10% OwnerSep 23Buy2.83300849298,873Sep 27 05:23 PM
ALSTODT LANCEPresident, CEO, COBSep 22Buy2.92200584182,921Sep 23 09:55 AM
Silva FranciscoVP of Research and DevelopmentAug 29Buy3.212,8169,048163,572Sep 09 06:17 PM
Silva FranciscoVP of Research and DevelopmentAug 29Buy3.323071,01912,136Sep 09 06:17 PM
Silva FranciscoVP of Research and DevelopmentAug 26Buy3.352,6008,710160,756Sep 09 06:17 PM
Silva FranciscoVP of Research and DevelopmentAug 26Sale3.393,95813,410158,156Sep 09 06:17 PM
Broadrick Dale10% OwnerJul 13Buy3.00200600298,573Jul 15 11:46 AM
Broadrick Dale10% OwnerJul 12Buy2.979002,673298,373Jul 15 11:46 AM
ALSTODT LANCEPresident, CEO, COBJul 12Buy2.957002,065182,721Jul 13 08:25 AM
Broadrick Dale10% OwnerJul 06Buy3.38100338297,473Jul 15 11:46 AM
Broadrick Dale10% OwnerJun 30Buy3.081,9005,850297,373Jul 05 06:10 PM
ALSTODT LANCEPresident, CEO, COBJun 30Buy3.101,1003,408182,021Jul 01 09:20 AM
Broadrick Dale10% OwnerJun 21Buy3.68100368295,473Jun 23 03:42 PM
Broadrick Dale10% OwnerJun 17Buy3.806002,282295,373Jun 23 03:42 PM
Broadrick Dale10% OwnerJun 16Buy3.812,0007,611294,773Jun 17 05:05 PM
ALSTODT LANCEPresident, CEO, COBJun 16Buy3.736002,238180,921Jun 17 04:02 PM
Broadrick Dale10% OwnerJun 15Buy3.721,2004,464292,773Jun 17 05:05 PM
ALSTODT LANCEPresident, CEO, COBJun 15Buy3.687002,578180,321Jun 15 05:30 PM
Kristal Robert EugeneChief Financial OfficerJun 15Buy3.611947007,994Jun 15 05:50 PM
ALSTODT LANCEPresident, CEO, COBJun 14Buy3.915001,956179,621Jun 15 11:01 AM
Broadrick Dale10% OwnerJun 13Buy3.921,3005,097291,573Jun 15 04:45 PM
ALSTODT LANCEPresident, CEO, COBJun 13Buy3.95200790179,121Jun 14 11:55 AM
Broadrick Dale10% OwnerJun 10Buy4.236002,540290,273Jun 13 03:33 PM
Broadrick Dale10% OwnerJun 09Buy4.271,0004,266289,673Jun 13 03:33 PM
Broadrick Dale10% OwnerJun 08Buy4.332,40010,395288,673Jun 09 04:42 PM
ALSTODT LANCEPresident, CEO, COBJun 08Buy4.28100428178,921Jun 09 11:41 AM
Broadrick Dale10% OwnerJun 07Buy4.723,60017,003286,273Jun 09 04:42 PM
Kristal Robert EugeneChief Financial OfficerJun 07Buy4.562009127,800Jun 07 12:22 PM
Broadrick Dale10% OwnerJun 06Buy4.933,00014,798282,673Jun 07 01:52 PM
Broadrick Dale10% OwnerJun 03Buy4.901,2005,879279,673Jun 07 01:52 PM
Broadrick Dale10% OwnerJun 02Buy4.691,0004,688278,473Jun 06 01:35 PM
Broadrick Dale10% OwnerJun 01Buy4.469,21341,122277,473Jun 03 04:03 PM
ALSTODT LANCEPresident, CEO, COBJun 01Buy4.60200920178,821Jun 03 06:58 AM
Broadrick Dale10% OwnerMay 27Buy3.6110,95739,592268,260Jun 01 04:30 PM
Broadrick Dale10% OwnerMay 26Buy3.514,95017,364259,303May 31 05:18 PM
ALSTODT LANCEPresident, CEO, COBMay 26Buy3.522,7009,494178,621May 27 10:23 AM
Broadrick Dale10% OwnerMay 26Sale3.442,0006,876257,303May 31 05:18 PM
ALSTODT LANCEPresident, CEO, COBMay 02Buy3.954001,579175,921May 02 05:14 PM
Kristal Robert EugeneChief Financial OfficerApr 08Buy5.717,60043,3967,600Apr 11 10:47 AM
Broadrick Dale10% OwnerApr 06Buy5.662,50014,150254,353Apr 08 04:23 PM
Broadrick Dale10% OwnerApr 05Buy5.7146,000262,640251,853Apr 07 04:15 PM
Broadrick Dale10% OwnerMar 31Buy4.7210,70050,488316,972Apr 01 04:54 PM
Broadrick Dale10% OwnerMar 29Buy5.125,00025,600306,272Apr 01 04:54 PM